A prescription at discharge improves long-term adherence for secondary stroke prevention

Journal of Stroke and Cerebrovascular Diseases

Volumn 23, Issue 9, 2014, Pages 2308-2315

  Tsai, Jenny P ^a   Rochon, Paula A ^b,c,d   Raptis, Stavroula ^e   Bronskill, Susan E ^c,d   Bell, Chaim M ^c,d,f   Saposnik, Gustavo ^c,d,e  

^a UNIVERSITY OF TORONTO   (Canada)

^b WOMEN S COLLEGE HOSPITAL   (Canada)

^c INSTITUTE FOR CLINICAL EVALUATIVE SCIENCES   (Canada)

^d UNIVERSITY OF TORONTO   (Canada)

^e ST MICHAEL'S HOSPITAL   (Canada)

^f MOUNT SINAI HOSPITAL   (Canada)

Author keywords

Ischemic stroke; medication; outcomes; stroke prevention

Indexed keywords

ANGIOTENSIN RECEPTOR ANTAGONIST; ANTIHYPERTENSIVE AGENT; ANTILIPEMIC AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR;

AGED; AMBULATORY CARE; ANTIHYPERTENSIVE THERAPY; ARTICLE; BRAIN ISCHEMIA; CHARLSON COMORBIDITY INDEX; COHORT ANALYSIS; DISEASE SEVERITY; DRUG EXPOSURE; FOLLOW UP; HOSPITAL ADMISSION; HOSPITAL DISCHARGE; HOSPITAL PATIENT; HUMAN; LONG TERM CARE; MAJOR CLINICAL STUDY; MEDICATION COMPLIANCE; OUTCOME ASSESSMENT; PATIENT COMPLIANCE; PRESCRIPTION; RECURRENCE RISK; RETROSPECTIVE STUDY; SECONDARY PREVENTION; STROKE PATIENT; TRANSIENT ISCHEMIC ATTACK; AGE; FACTUAL DATABASE; FEMALE; MALE; STATISTICS AND NUMERICAL DATA; STROKE; TREATMENT OUTCOME; VERY ELDERLY;

AGE FACTORS; AGED; AGED, 80 AND OVER; ANTIHYPERTENSIVE AGENTS; BRAIN ISCHEMIA; COHORT STUDIES; DATABASES, FACTUAL; DRUG PRESCRIPTIONS; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; PATIENT COMPLIANCE; PATIENT DISCHARGE; RETROSPECTIVE STUDIES; SECONDARY PREVENTION; STROKE; TREATMENT OUTCOME;

EID: 84907993834     PISSN: 10523057     EISSN: 15328511     Source Type: Journal    
DOI: 10.1016/j.jstrokecerebrovasdis.2014.04.026     Document Type: Article

References (31)

1. National Center for Health Statistics. NCHS Data Brief. 2012;95:1-8.
2. A.J. Coull Population based study of early risk of stroke after transient ischaemic attack or minor stroke: implications for public education and organisation of services BMJ 328 2004 326
3. L.B. Goldstein, and P.M. Rothwell Advances in prevention and health services delivery 2010-2011 Stroke 43 2012 298 299
4. T. Ohira Risk factors for ischemic stroke subtypes: the Atherosclerosis Risk in Communities study Stroke 37 2006 2493 2498
5. C.D. Bushnell, D.M. Olson, and X. Zhao Secondary preventive medication persistence and adherence 1 year after stroke Neurology 77 2011 1182 1190
6. E.L. Glader, M. Sjolander, M. Eriksson, and M. Lundberg Persistent use of secondary preventive drugs declines rapidly during the first 2 years after stroke Stroke 41 2010 397 401
7. B. Ovbiagele, J.L. Saver, and A. Fredieu In-hospital initiation of secondary stroke prevention therapies yields high rates of adherence at follow-up Stroke 35 2004 2879 2883
8. S. Perreault, A.Y. Yu, R. Cote, A. Dragomir, B. White-Guay, and S. Dumas Adherence to antihypertensive agents after ischemic stroke and risk of cardiovascular outcomes Neurology 79 2012 2037 2043
9. B.A. Fallis, I.A. Dhalla, J. Klemensberg, and C.M. Bell Primary medication non-Adherence after discharge from a general internal medicine service PLoS ONE 8 2013 e61735
10. Effects of ramipril on cardiovascular and microvascular outcomes in people with diabetes mellitus: results of the HOPE study and MICRO-HOPE substudy. Heart Outcomes Prevention Evaluation Study Investigators Lancet 355 2000 253 259
11. J. Schrader The ACCESS Study: evaluation of Acute Candesartan Cilexetil Therapy in Stroke Survivors Stroke 34 2003 1699 1703
12. PROGRESS Collaborative Group Randomised trial of a perindopril-based blood-pressure-lowering regimen among 6,105 individuals with previous stroke or transient ischaemic attack Lancet 358 2001 1033 1041
13. P. Amarenco, L.B. Goldstein, and M. Messig Relative and cumulative effects of lipid and blood pressure control in the Stroke Prevention by Aggressive Reduction in Cholesterol Levels trial Stroke 40 2009 2486 2492
14. Heart Protection Study Collaborative Group MRC/BHF Heart Protection Study of cholesterol lowering with simvastatin in 20,536 high-risk individuals: a randomised placebo-controlled trial Lancet 360 2002 7 22
15. T. Hillen, R. Dundas, and E. Lawrence Antithrombotic and antihypertensive management 3 months after ischemic stroke: a prospective study in an inner city population Stroke 31 2000 469 475
16. C.D. Bushnell Persistence with stroke prevention medications 3 months after hospitalization stroke prevention medication use after discharge Arch Neurol 67 2010 1456
17. F. Webster, G. Saposnik, and M.K. Kapral Organized outpatient care: stroke prevention clinic referrals are associated with reduced mortality after transient ischemic attack and ischemic stroke Stroke 42 2011 3176 3182
18. R. Hall, F. Khan, and C. O'Callaghan Ontario stroke evaluation report 2012: prescribing system solutions to improve stroke outcomes 2012 Institute for Clinical Evaluative Sciences Available at http://www.ices.on.ca/file/Stroke-Evaluation-Report-2012.pdf Accessed August 11, 2013
19. R. Cote, R.N. Battista, and C. Wolfson The Canadian Neurological Scale: validation and reliability assessment Neurology 39 1989 638 643
20. S.S. Franklin, K. Wachtell, and V. Papademetriou Cardiovascular morbidity and mortality in hypertensive patients with lower versus higher risk: a LIFE substudy Hypertension 46 2005 492 499
21. PROGRESS Effects of a perindopril-based blood pressure-lowering regimen on disability and dependency in 6105 patients with cerebrovascular disease: a randomized controlled trial Stroke 34 2003 2333 2338
22. ONTARGET Investigators, S. Yusuf, and K.K. Teo Telmisartan, ramipril, or both in patients at high risk for vascular events N Engl J Med 358 2008 1547 1559
23. C.A. Jackevicius, P. Li, and J.V. Tu Prevalence, predictors, and outcomes of primary nonadherence after acute myocardial infarction Circulation 117 2008 1028 1036
24. L. Osterberg, and T. Blaschke Adherence to medication N Engl J Med 353 2005 487 497
25. H.P. Adams, B.H. Bendixen, and L.J. Kappelle Classification of subtype of acute ischemic stroke. Definitions for use in a multicenter clinical trial. TOAST. Trial of Org 10172 in Acute Stroke Treatment Stroke 24 1993 35 41
26. G. Saposnik, J. Fang, and M. O'Donnell Escalating levels of access to in-hospital care and stroke mortality Stroke 39 2008 2522 2530
27. The Ontario Stroke Registry: Regional Stroke Centre Data. Available at: https://osr.ices.on.ca/OSRRCSNDatabases/RegionalStrokeCentreData.aspx. Accessed August 12, 2013.
28. G. Saposnik, M.D. Hill, and M. O'Donnell Variables associated with 7-day, 30-day, and 1-year fatality after ischemic stroke Stroke 39 2008 2318
29. D.G. Hackam, and J.D. Spence Combining multiple approaches for the secondary prevention of vascular events after stroke: a quantitative modeling study Stroke 38 2007 1881 1885
30. A.G. Thrift, J. Kim, and V. Douzmanian Discharge is a critical time to influence 10-year use of secondary prevention therapies for stroke Stroke 2013
31. G. Saposnik, J. Fang, and M.K. Kapral The iScore predicts effectiveness of thrombolytic therapy for acute ischemic stroke Stroke 43 2012 1315 1322